Turkiye Klinikleri Journal of Health Sciences

.: REVIEW
Üç Boyutlu Biyobasıma Bir Bakış ve Organ Basımı
An Overview of Three Dimensional Bioprinting and Organ Printing
Ali İhsan BÜLBÜLa, Serdar KÜÇÜKb
aKocaeli Üniversitesi Fen Bilimleri Enstitüsü, Biyomedikal Mühendisliği, Kocaeli, TÜRKİYE
bKocaeli Üniversitesi Teknoloji Fakültesi, Biyomedikal Mühendisliği, Kocaeli, TÜRKİYE
Turkiye Klinikleri J Health Sci. 2020;5(3):702-18
doi: 10.5336/healthsci.2019-72026
Article Language: TR
Full Text
ÖZET
 Bu çalışma, rejeneratif tıp dünyasında araştırmacılar tarafından 3 boyutlu (3B) biyobasım alanında yapılan çalışmalara ait bir analizdir. Konunun spesifikliği ve buna rağmen çok geniş yayın yelpazesine dağılması, çoklu disiplinli bilimsel yapıda olması nedenleriyle analiz etmek ve bir makale kapsamına sığdırmak zordur. Biyobasım, büyük oranda transplantasyon ve bir ölçüde ilaç keşfi ve toksikoloji araştırmalarında kullanılacak uygun doku ve organlara olan ihtiyacı gidermek amacıyla doku mühendisliğinde biyomalzemeler veya hücrelerle biyolojik yapıları in vivo veya in vitro üretmek için, laboratuvar çalışması ve/veya bilgisayar destekli biyoyazdırma işlemleridir. Bu işlemlerde özellikle yumuşak dokuları simüle edebilmesi, hidrofilik yapısı ve yüksek biyouyumluluğu sayesinde hidrojeller yoğun kullanılır. İskele yapıları hidrojellerle beraber dokulara temel oluşturur. İskelelerin ve dokuların üretiminde 3B biyoyazıcılar da kullanılmaktadır. Bu çalışmada, 3B biyobasım hakkında literatürdeki önemli bilgiler ve güncel uygulama örnekleri derlenmiştir. Ayrıca organ ve özellikle böbrek basımı üzerine yapılan çalışmalar irdelenmiştir. 3B biyobasımın nispeten yeni olmasından dolayı gelişim süreci ile yapılan çalışmalar, bu teknolojiyi yapılandırmakta ve bu anlamda tanımını ve içeriğini oluşturmaktadır. Bundan dolayı ve artan ilginin de gösterdiği önemi nedeniyle bu makalede, 3B biyobasımın okunabilirliğinin artırılması da amaçlanmıştır.

Anahtar Kelimeler: Doku mühendisliği; biyobaskı; hidrojel; iskele; böbrek
ABSTRACT
 This review is an analysis of the studies carried out in the field of three-dimensional bioprinting by people working in the regenerative medicine world. Due to the specificity of the subject and its distribution to a wide range of publications and its multidisciplinary scientific structure, it is difficult to analyze and fit within the scope of an article. Bioprinting is a laboratory study and/or a computer-aided process to produce biomaterials or cells in tissue engineering in vivo or in vitro for the purpose of relieving the need for appropriate tissues and organs to be used in a large extent in transplantation and to some extent in drug discovery and toxicology research. In these processes, hydrogels are used intensively due to their ability to simulate soft tissues, hydrophilic structure and high biocompatibility. Scaffold structures are the basis for the tissues together with hydrogels. Three-dimensional bioprinters are also used in the production of scaffold and tissue. In this study, important information and actual application examples about the three dimensional bioprint literature have been compiled. In addition, studies on organ and especially kidney compression are examined. Due to the fact that the three-dimensional bioprint is relatively new, the studies carried out with the development process define this technology and in this sense constitute the definition and the content. Therefore and due to the importance of increasing interest, it is aimed to increase the readability of the three-dimensional bioprint.

Keywords: Tissue engineering; bioprinting; hydrogel; scaffold; kidney
REFERENCES:
  1. Vacant JP, Vacanti CA. Principles of Tissue Engineering. 4th ed. Academic Press; 2014.
  2. [Republic of Turkey Ministry of Health Public Organ Transplant Statistics] 2019 [31.02.2019]. Available from: [Link] 
  3. Ozbolat IT, Yu Y. Bioprinting toward organ fabrication: challenges and future trends. IEEE Trans Biomed Eng. 2013;60(3):691-9. [Crossref]  [PubMed] 
  4. Gao G, Huang Y, Schilling AF, Hubbell K, Cui X. Organ bioprinting: are we there yet? Adv Healthc Mater. 2018;7(1). [Crossref]  [PubMed] 
  5. Buchholz FL, Graham AT. Modern Superabsorbent Polymer Technology. New York: Wiley-VCH; 1998. p.279.
  6. Li Y, Huang G, Zhang X, Li B, Chen Y, Lu T, et al. Magnetic hydrogels and their potential biomedical applications. Advanced Functional Materials. 2013;23(6):660-72. [Crossref] 
  7. Ahmed EM. Hydrogel: Preparation, characterization, and applications: A review. J Adv Res. 2015;6(2):105-21. [Crossref]  [PubMed]  [PMC] 
  8. Wen T, Wang Y. Sidelobe suppression in CR-OFDM system by adding extended data carriers. Communications and Network. 2013;5(03):327-32. [Crossref] 
  9. Ahmed EM, Aggor FS, Awad AM, El-Aref AT. An innovative method for preparation of nanometal hydroxide superabsorbent hydrogel. Carbohydr Polym. 2013;91(2):693-8. [Crossref]  [PubMed] 
  10. Sentetik Hidrojel 2017. [Link] 
  11. Burkert S, Schmidt T, Gohs U, Dorschner H, Arndt K-F. Cross-linking of poly (N-vinyl pyrrolidone) films by electron beam irradiation. Radiation Physics and Chemistry. 2007;76(8-9):1324-8. [Crossref] 
  12. Zohuriaan-Mehr MJ, Kabiri K. Superabsorbent polymer materials: a review. Iranian polymer journal. 2008;17(6):451. [Link] 
  13. Talaat H, Sorour M, Aboulnour A, Shaalan H, Ahmed EM, Awad A, et al. Development of a multi-component fertilizing hydrogel with relevant techno-economic indicators. Am-Euras J Agric Environ Sci. 2008;3(5):764-70. [Link] 
  14. Eichhorn SJ. Cellulose nanowhiskers: promising materials for advanced applications. Soft Matter. 2011;7(2):303-15. [Crossref] 
  15. Eichhorn SJ, Dufresne A, Aranguren M, Marcovich N, Capadona J, Rowan S, et al. Review: current international research into cellulose nanofibres and nanocomposites. Journal of Materials Science. 2010;45(1):1. [Crossref] 
  16. Missoum K, Belgacem MN, Bras J. Nanofibrillated cellulose surface modification: a review. Materials (Basel). 2013;6(5):1745-66. [Crossref]  [PubMed]  [PMC] 
  17. Janeček ER, McKee JR, Tan CS, Nykänen A, Kettunen M, Laine J, et al. Hybrid supramolecular and colloidal hydrogels that bridge multiple length scales. Angew Chem Int Ed Engl. 2015;54(18):5383-8. [Crossref]  [PubMed]  [PMC] 
  18. Cohen S, Ba-o MC, Cima LG, Allcock HR, Vacanti JP, Vacanti CA, et al. Design of synthetic polymeric structures for cell transplantation and tissue engineering. Clin Mater. 1993;13(1-4):3-10. [Crossref]  [PubMed] 
  19. Loh QL, Choong C. Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size. Tissue Eng Part B Rev. 2013;19(6):485-502. [Crossref]  [PubMed]  [PMC] 
  20. Salerno A, Di Maio E, Iannace S, Netti P. Tailoring the pore structure of PCL scaffolds for tissue engineering prepared via gas foaming of multi-phase blends. Journal of Porous Materials. 2012;19(2):181-8. [Crossref] 
  21. Hollister SJ. Porous scaffold design for tissue engineering. Nature materials. 2005;4(7):518. [Crossref]  [PubMed] 
  22. Causa F, Netti PA, Ambrosio L. A multi-functional scaffold for tissue regeneration: the need to engineer a tissue analogue. Biomaterials. 2007;28(34):5093-9. [Crossref]  [PubMed] 
  23. Story BJ, Wagner WR, Gaisser DM, Cook SD, Rust-Dawicki AM. In vivo performance of a modified CSTi dental implant coating. Int J Oral Maxillofac Implants. 1998;13(6):749-57. [PubMed] 
  24. Chevalier E, Chulia D, Pouget C, Viana M. Fabrication of porous substrates: a review of processes using pore forming agents in the biomaterial field. J Pharm Sci. 2008;97(3):1135-54. [Crossref]  [PubMed]  [PMC] 
  25. Sung HJ, Meredith C, Johnson C, Galis ZS. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials. 2004;25(26):5735-42. [Crossref]  [PubMed] 
  26. de Vos P, Marchetti P. Encapsulation of pancreatic islets for transplantation in diabetes: the untouchable islets. Trends Mol Med. 2002;8(8):363-6. [Crossref]  [PubMed] 
  27. Keskar V, Marion NW, Mao JJ, Gemeinhart RA. In vitro evaluation of macroporous hydrogels to facilitate stem cell infiltration, growth, and mineralization. Tissue Eng Part A. 2009;15(7):1695-707. [Crossref]  [PubMed]  [PMC] 
  28. Luu YK, Kim K, Hsiao BS, Chu B, Hadjiargyrou M. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. J Control Release. 2003;89(2):341-53. [Crossref]  [PubMed] 
  29. Cabral J, Moratti SC. Hydrogels for biomedical applications. Future Med Chem. 2011;3(15):1877-88. [Crossref]  [PubMed] 
  30. Eiselt P, Yeh J, Latvala RK, Shea LD, Mooney DJ. Porous carriers for biomedical applications based on alginate hydrogels. Biomaterials. 2000;21(19):1921-7. [Crossref]  [PubMed] 
  31. Kaigler D, Wang Z, Horger K, Mooney DJ, Krebsbach PH. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res. 2006;21(5):735-44. [Crossref]  [PubMed] 
  32. Chiu YC, Larson JC, Isom A Jr, Brey EM. Generation of porous poly(ethylene glycol) hydrogels by salt leaching. Tissue Eng Part C Methods. 2010;16(5):905-12. [Crossref]  [PubMed] 
  33. Yang S, Leong KF, Du Z, Chua CK. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng. 2001;7(6):679-89. [Crossref]  [PubMed] 
  34. Yang S, Leong KF, Du Z, Chua CK. The design of scaffolds for use in tissue engineering. Part II. Rapid prototyping techniques. Tissue Eng. 2002;8(1):1-11. [Crossref]  [PubMed] 
  35. Leong KF, Cheah CM, Chua CK. Solid freeform fabrication of three-dimensional scaffolds for engineering replacement tissues and organs. Biomaterials. 2003;24(13):2363-78. [Crossref]  [PubMed] 
  36. 36.Yeong WY, Chua CK, Leong KF, Chandrasekaran M. Rapid prototyping in tissue engineering: challenges and potential. Trends Biotechnol. 2004;22(12):643-52. [Crossref]  [PubMed] 
  37. Cheah C, Chua C, Leong K, Chua S. Development of a tissue engineering scaffold structure library for rapid prototyping. Part 1: investigation and classification. The International Journal of Advanced Manufacturing Technology. 2003;21(4):291-301. [Crossref] 
  38. Cheah C, Chua C, Leong K, Chua S. Development of a tissue engineering scaffold structure library for rapid prototyping. Part 2: parametric library and assembly program. The International Journal of Advanced Manufacturing Technology. 2003;21(4):302-12. [Crossref] 
  39. Cheah CM, Chua CK, Leong KF, Cheong CH, Naing MW. Automatic algorithm for generating complex polyhedral scaffold structures for tissue engineering. Tissue Eng. 2004;10(3-4):595-610. [Crossref]  [PubMed] 
  40. Sudarmadji N, Tan JY, Leong KF, Chua CK, Loh YT. Investigation of the mechanical properties and porosity relationships in selective laser-sintered polyhedral for functionally graded scaffolds. Acta Biomater. 2011;7(2):530-7. [Crossref]  [PubMed] 
  41. Naing M, Chua C, Leong K, Wang Y. Fabrication of customised scaffolds using computer-aided design and rapid prototyping techniques. Rapid Prototyping Journal. 2005;11(4):249-59. [Crossref] 
  42. Leong KF, Chua CK, Sudarmadji N, Yeong WY. Engineering functionally graded tissue engineering scaffolds. J Mech Behav Biomed Mater. 2008;1(2):140-52. [Crossref]  [PubMed] 
  43. Sudarmadji N, Chua CK, Leong KF. The development of computer-aided system for tissue scaffolds (CASTS) system for functionally graded tissue-engineering scaffolds. Methods Mol Biol. 2012;868:111-23. [Crossref]  [PubMed] 
  44. Chua C, Sudarmadji N, Leong K, Chou S, Lim S, Firdaus W. Process flow for designing functionally graded tissue engineering scaffolds. Innovative Developments in Design and Manufacturing: CRC Press; 2009. p. 63-8.
  45. Chua C, Leong K, Sudarmadji N, Liu M, Chou S. Selective laser sintering of functionally graded tissue scaffolds. MRS bulletin. 2011;36(12):1006-14. [Crossref] 
  46. Cai S, Xi J, Chua CK. A novel bone scaffold design approach based on shape function and all-hexahedral mesh refinement. Methods Mol Biol. 2012;868:45-55. [Crossref]  [PubMed] 
  47. Irvine SA, Venkatraman SS. Bioprinting and Differentiation of Stem Cells. Molecules. 2016;21(9):1188. [Crossref]  [PubMed]  [PMC] 
  48. An J, Teoh JEM, Suntornnond R, Chua CK. Design and 3D printing of scaffolds and tissues. Engineering. 2015;1(2):261-8. [Crossref] 
  49. Rouwkema J, Rivron NC, van Blitterswijk CA. Vascularization in tissue engineering. Trends Biotechnol. 2008;26(8):434-41. [Crossref]  [PubMed] 
  50. Menger MD, Hammersen F, Walter P, Messmer K. Neovascularization of prosthetic vascular grafts. Quantitative analysis of angiogenesis and microhemodynamics by means of intravital microscopy. Thorac Cardiovasc Surg. 1990;38(3):139-45. [Crossref]  [PubMed] 
  51. Langer S, Sinitsina I, Biberthaler P, Krombach F, Messmer K. Revascularization of transplanted adipose tissue: a study in the dorsal skinfold chamber of hamsters. Ann Plast Surg. 2002;48(1):53-9. [Crossref]  [PubMed] 
  52. Menger MD, Vajkoczy P, Beger C, Messmer K. Orientation of microvascular blood flow in pancreatic islet isografts. J Clin Invest. 1994;93(5):2280-5. [Crossref]  [PubMed]  [PMC] 
  53. Druecke D, Langer S, Lamme E, Pieper J, Ugarkovic M, Steinau HU, et al. Neovascularization of poly(ether ester) block-copolymer scaffolds in vivo: long-term investigations using intravital fluorescent microscopy. J Biomed Mater Res A. 2004;68(1):10-8. [Crossref]  [PubMed] 
  54. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials. 2005;26(27):5474-91. [Crossref]  [PubMed] 
  55. Murphy SV, Atala A. 3D bioprinting of tissues and organs. Nat Biotechnol. 2014;32(8):773-85. [Crossref]  [PubMed] 
  56. Ovsianikov A, Gruene M, Pflaum M, Koch L, Maiorana F, Wilhelmi M, et al. Laser printing of cells into 3D scaffolds. Biofabrication. 2010;2(1):014104. [Crossref]  [PubMed] 
  57. Boland T, Xu T, Damon B, Cui X. Application of inkjet printing to tissue engineering. Biotechnol J. 2006;1(9):910-7. [Crossref]  [PubMed] 
  58. 58.Xu T, Kincaid H, Atala A, Yoo JJ. High-throughput production of single-cell microparticles using an inkjet printing technology. Journal of Manufacturing Science and Engineering. 2008;130(2):021017. [Crossref] 
  59. Xu C, Chai W, Huang Y, Markwald RR. Scaffold-free inkjet printing of three-dimensional zigzag cellular tubes. Biotechnol Bioeng. 2012;109(12):3152-60. [Crossref]  [PubMed] 
  60. Cui X, Boland T, D'Lima DD, Lotz MK. Thermal inkjet printing in tissue engineering and regenerative medicine. Recent Pat Drug Deliv Formul. 2012;6(2):149-55. [Crossref]  [PubMed]  [PMC] 
  61. Okamoto T, Suzuki T, Yamamoto N. Microarray fabrication with covalent attachment of DNA using bubble jet technology. Nat Biotechnol. 2000;18(4):438-41. [Crossref]  [PubMed] 
  62. Xu T, Gregory CA, Molnar P, Cui X, Jalota S, Bhaduri SB, et al. Viability and electrophysiology of neural cell structures generated by the inkjet printing method. Biomaterials. 2006;27(19):3580-8. [Crossref]  [PubMed]  [PMC] 
  63. Tekin E, Smith PJ, Schubert US. Inkjet printing as a deposition and patterning tool for polymers and inorganic particles. Soft Matter. 2008;4(4):703-13. [Crossref]  [PubMed] 
  64. Saunders RE, Gough JE, Derby B. Delivery of human fibroblast cells by piezoelectric drop-on-demand inkjet printing. Biomaterials. 2008;29(2):193-203. [Crossref]  [PubMed] 
  65. Nakamura M, Kobayashi A, Takagi F, Watanabe A, Hiruma Y, Ohuchi K, et al. Biocompatible inkjet printing technique for designed seeding of individual living cells. Tissue Eng. 2005;11(11-12):1658-66. [Crossref]  [PubMed] 
  66. Khalil S, Sun W. Biopolymer deposition for freeform fabrication of hydrogel tissue constructs. Materials Science and Engineering: C. 2007;27(3):469-78. [Crossref] 
  67. Smith CM, Stone AL, Parkhill RL, Stewart RL, Simpkins MW, Kachurin AM, et al. Three-dimensional bioassembly tool for generating viable tissue-engineered constructs. Tissue Eng. 2004;10(9-10):1566-76. [Crossref]  [PubMed] 
  68. Lee W, Lee V, Polio S, Keegan P, Lee JH, Fischer K, et al. On-demand three-dimensional freeform fabrication of multi-layered hydrogel scaffold with fluidic channels. Biotechnol Bioeng. 2010;105(6):1178-86. [Crossref]  [PubMed] 
  69. Fedorovich NE, Swennen I, Girones J, Moroni L, van Blitterswijk CA, Schacht E, et al. Evaluation of photocrosslinked Lutrol hydrogel for tissue printing applications. Biomacromolecules. 2009;10(7):1689-96. [Crossref]  [PubMed] 
  70. Visser J, Peters B, Burger TJ, Boomstra J, Dhert WJ, Melchels FP, et al. Biofabrication of multi-material anatomically shaped tissue constructs. Biofabrication. 2013;5(3):035007. [Crossref]  [PubMed] 
  71. Marga F, Jakab K, Khatiwala C, Shephard B, Dorfman S, Forgacs G. Organ Printing: A Novel Tissue Engineering Paradigm. 5th European Conference of the International Federation for Medical and Biological Engineering; Springer; 2011. [Crossref] 
  72. Mironov V, Visconti RP, Kasyanov V, Forgacs G, Drake CJ, Markwald RR. Organ printing: tissue spheroids as building blocks. Biomaterials. 2009;30(12):2164-74. [Crossref]  [PubMed]  [PMC] 
  73. Marga F, Jakab K, Khatiwala C, Shepherd B, Dorfman S, Hubbard B, et al. Toward engineering functional organ modules by additive manufacturing. Biofabrication. 2012;4(2):022001. [Crossref]  [PubMed] 
  74. Fedorovich NE, Schuurman W, Wijnberg HM, Prins HJ, van Weeren PR, Malda J, et al. Biofabrication of osteochondral tissue equivalents by printing topologically defined, cell-laden hydrogel scaffolds. Tissue Eng Part C Methods. 2012;18(1):33-44. [Crossref]  [PubMed]  [PMC] 
  75. Kolesky DB, Truby RL, Gladman AS, Busbee TA, Homan KA, Lewis JA. 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs. Adv Mater. 2014;26(19):3124-30. [Crossref]  [PubMed] 
  76. Wu C, Luo Y, Cuniberti G, Xiao Y, Gelinsky M. Three-dimensional printing of hierarchical and tough mesoporous bioactive glass scaffolds with a controllable pore architecture, excellent mechanical strength and mineralization ability. Acta Biomater. 2011;7(6):2644-50. [Crossref]  [PubMed] 
  77. Ghosh S, Parker ST, Wang X, Kaplan DL, Lewis JA. Direct‐write assembly of microperiodic silk fibroin scaffolds for tissue engineering applications. Advanced Functional Materials. 2008;18(13):1883-9. [Crossref] 
  78. Curodeau A, Sachs E, Caldarise S. Design and fabrication of cast orthopedic implants with freeform surface textures from 3-D printed ceramic shell. J Biomed Mater Res. 2000;53(5):525-35. [Crossref]  [PubMed] 
  79. Kim SS, Utsunomiya H, Koski JA, Wu BM, Cima MJ, Sohn J, et al. Survival and function of hepatocytes on a novel three-dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels. Ann Surg. 1998;228(1):8-13. [Crossref]  [PubMed]  [PMC] 
  80. Yung CW, Wu LQ, Tullman JA, Payne GF, Bentley WE, Barbari TA. Transglutaminase crosslinked gelatin as a tissue engineering scaffold. J Biomed Mater Res A. 2007;83(4):1039-46. [Crossref]  [PubMed] 
  81. Yan Y, Wang X, Xiong Z, Liu H, Liu F, Lin F, et al. Direct construction of a three-dimensional structure with cells and hydrogel. Journal of bioactive and compatible polymers. 2005;20(3):259-69. [Crossref] 
  82. Chua C, Liu M, Chou S. Additive manufacturing-assisted scaffold-based tissue engineering. In: da Silva Bartolo PJ, ed. Innovative Developments in Virtual and Physical Prototyping. Proceedings of the 5th International Conference on Advanced Research in Virtual and Rapid Prototyping, Leiria, Portugal; 2011. [Crossref]  [PubMed] 
  83. Yeong W-Y, Chua C-K, Leong K-F, Chandrasekaran M, Lee M-W. Indirect fabrication of collagen scaffold based on inkjet printing technique. Rapid Prototyping Journal. 2006;12(4):229-37. [Crossref] 
  84. Yeong WY, Chua CK, Leong KF, Chandrasekaran M, Lee MW. Comparison of drying methods in the fabrication of collagen scaffold via indirect rapid prototyping. J Biomed Mater Res B Appl Biomater. 2007;82(1):260-6. [Crossref]  [PubMed] 
  85. 85.Liu MJ, Chou SM, Chua CK, Tay BC, Ng BK. The development of silk fibroin scaffolds using an indirect rapid prototyping approach: morphological analysis and cell growth monitoring by spectral-domain optical coherence tomography. Med Eng Phys. 2013;35(2):253-62. [Crossref]  [PubMed] 
  86. Chen CH, Liu JM, Chua CK, Chou SM, Shyu VB, Chen JP. Cartilage Tissue Engineering with Silk Fibroin Scaffolds Fabricated by Indirect Additive Manufacturing Technology. Materials (Basel). 2014;7(3):2104-19. [Crossref]  [PubMed]  [PMC] 
  87. Ozler SB, Bakirci E, Kucukgul C, Koc B. Three-dimensional direct cell bioprinting for tissue engineering. J Biomed Mater Res B Appl Biomater. 2017;105(8):2530-44. [Crossref]  [PubMed] 
  88. Gopinathan J, Noh I. Recent trends in bioinks for 3D printing. Biomater Res. 2018;22:11. [Crossref]  [PubMed]  [PMC] 
  89. Hospodiuk M, Dey M, Sosnoski D, Ozbolat IT. The bioink: A comprehensive review on bioprintable materials. Biotechnol Adv. 2017;35(2):217-39. [Crossref]  [PubMed] 
  90. Jang J, Park JY, Gao G, Cho DW. Biomaterials-based 3D cell printing for next-generation therapeutics and diagnostics. Biomaterials. 2018;156:88-106. [Crossref]  [PubMed] 
  91. Kucukgul C, Ozler SB, Inci I, Karakas E, Irmak S, Gozuacik D, et al. 3D bioprinting of biomimetic aortic vascular constructs with self-supporting cells. Biotechnol Bioeng. 2015;112(4):811-21. [Crossref]  [PubMed] 
  92. Kim JE, Kim SH, Jung Y. Current status of three-dimensional printing inks for soft tissue regeneration. Tissue Eng Regen Med. 2016;13(6):636-46. [Crossref]  [PubMed]  [PMC] 
  93. Duarte Campos DF, Blaeser A, Korsten A, Neuss S, Jäkel J, Vogt M, et al. The stiffness and structure of three-dimensional printed hydrogels direct the differentiation of mesenchymal stromal cells toward adipogenic and osteogenic lineages. Tissue Eng Part A. 2015;21(3-4):740-56. [Crossref]  [PubMed] 
  94. Christensen K, Xu C, Chai W, Zhang Z, Fu J, Huang Y. Freeform inkjet printing of cellular structures with bifurcations. Biotechnol Bioeng. 2015;112(5):1047-55. [Crossref]  [PubMed] 
  95. AnilKumar S, Allen SC, Tasnim N, Akter T, Park S, Kumar A, et al. The applicability of furfuryl-gelatin as a novel bioink for tissue engineering applications. J Biomed Mater Res B Appl Biomater. 2019;107(2):314-23. [Crossref]  [PubMed]  [PMC] 
  96. 96.Pati F, Jang J, Ha DH, Won Kim S, Rhie JW, Shim JH, et al. Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink. Nat Commun. 2014;5:3935. [Crossref]  [PubMed]  [PMC] 
  97. Jang J, Park HJ, Kim SW, Kim H, Park JY, Na SJ, et al. 3D printed complex tissue construct using stem cell-laden decellularized extracellular matrix bioinks for cardiac repair. Biomaterials. 2017;112:264-74. [Crossref]  [PubMed] 
  98. Zheng Z, Wu J, Liu M, Wang H, Li C, Rodriguez MJ, et al. 3D bioprinting of self-standing silk-based bioink. Adv Healthc Mater. 2018;7(6):e1701026. [Crossref]  [PubMed] 
  99. Schiele NR, Chrisey DB, Corr DT. Gelatin-based laser direct-write technique for the precise spatial patterning of cells. Tissue Eng Part C Methods. 2011;17(3):289-98. [Crossref]  [PubMed]  [PMC] 
  100. Pimentel C R, Ko SK, Caviglia C, Wolff A, Emnéus J, Keller SS, et al. Three-dimensional fabrication of thick and densely populated soft constructs with complex and actively perfused channel network. Acta Biomater. 2018;65:174-84. [Crossref]  [PubMed] 
  101. Duan B, Hockaday LA, Kang KH, Butcher JT. 3D bioprinting of heterogeneous aortic valve conduits with alginate/gelatin hydrogels. J Biomed Mater Res A. 2013;101(5):1255-64. [Crossref]  [PubMed]  [PMC] 
  102. Sakai S, Ohi H, Hotta T, Kamei H, Taya M. Differentiation potential of human adipose stem cells bioprinted with hyaluronic acid/gelatin-based bioink through microextrusion and visible light-initiated crosslinking. Biopolymers. 2018;109(2). [Crossref]  [PubMed] 
  103. Law N, Doney B, Glover H, Qin Y, Aman ZM, Sercombe TB, et al. Characterisation of hyaluronic acid methylcellulose hydrogels for 3D bioprinting. J Mech Behav Biomed Mater. 2018;77:389-99. [Crossref]  [PubMed] 
  104. 104.Billiet T, Gevaert E, De Schryver T, Cornelissen M, Dubruel P. The 3D printing of gelatin methacrylamide cell-laden tissue-engineered constructs with high cell viability. Biomaterials. 2014;35(1):49-62. [Crossref]  [PubMed] 
  105. Levato R, Webb WR, Otto IA, Mensinga A, Zhang Y, van Rijen M, et al. The bio in the ink: cartilage regeneration with bioprintable hydrogels and articular cartilage-derived progenitor cells. Acta Biomater. 2017;61:41-53. [Crossref]  [PubMed]  [PMC] 
  106. 106.Mouser VH, Melchels FP, Visser J, Dhert WJ, Gawlitta D, Malda J. Yield stress determines bioprintability of hydrogels based on gelatin-methacryloyl and gellan gum for cartilage bioprinting. Biofabrication. 2016;8(3):035003. [Crossref]  [PubMed]  [PMC] 
  107. Brown GCJ, Lim KS, Farrugia BL, Hooper GJ, Woodfield TBF. Covalent incorporation of heparin improves chondrogenesis in photocurable gelatin-methacryloyl hydrogels. Macromol Biosci. 2017;17(12). [Crossref]  [PubMed] 
  108. Ali M, Pr AK, Yoo JJ, Zahran F, Atala A, Lee SJ. A photo-crosslinkable kidney ECM-derived bioink accelerates renal tissue formation. Adv Healtc Mater. 2019;8(7):e1800992. [Crossref]  [PubMed]  [PMC] 
  109. Yang X, Lu Z, Wu H, Li W, Zheng L, Zhao J. Collagen-alginate as bioink for three-dimensional (3D) cell printing based cartilage tissue engineering. Mater Sci Eng C Mater Biol Appl. 2018;83:195-201. [Crossref]  [PubMed] 
  110. Jeon O, Bin Lee Y, Hinton TJ, Feinberg AW, Alsberg E. Cryopreserved cell-laden alginate microgel bioink for 3D bioprinting of living tissues. Mater Today Chem. 2019;12:61-70. [Crossref]  [PubMed]  [PMC] 
  111. Gao G, Yonezawa T, Hubbell K, Dai G, Cui X. Inkjet-bioprinted acrylated peptides and PEG hydrogel with human mesenchymal stem cells promote robust bone and cartilage formation with minimal printhead clogging. Biotechnol J. 2015;10(10):1568-77. [Crossref]  [PubMed] 
  112. Müller M, Becher J, Schnabelrauch M, Zenobi-Wong M. Nanostructured Pluronic hydrogels as bioinks for 3D bioprinting. Biofabrication. 2015;7(3):035006. [Crossref]  [PubMed] 
  113. Mozetic P, Giannitelli SM, Gori M, Trombetta M, Rainer A. Engineering muscle cell alignment through 3D bioprinting. J Biomed Mater Res A. 2017;105(9):2582-8. [Crossref]  [PubMed] 
  114. An J, Chua CK, Yu T, Li H, Tan LP. Advanced nanobiomaterial strategies for the development of organized tissue engineering constructs. Nanomedicine (Lond). 2013;8(4):591-602. [Crossref]  [PubMed] 
  115. European Commision. Journalist Workshop on organ donation and transplantation, recent facts and figures. 2014. [Link] 
  116. 116.Weiner DE. Public health consequences of chronic kidney disease. Clin Pharmacol Ther. 2009;86(5):566-9. [Crossref]  [PubMed]  [PMC] 
  117. Bertram JF, Douglas-Denton RN, Diouf B, Hughson MD, Hoy WE. Human nephron number: implications for health and disease. Pediatr Nephrol. 2011;26(9):1529-33. [Crossref]  [PubMed] 
  118. Ogunlade O, Connell JJ, Huang JL, Zhang E, Lythgoe MF, Long DA, et al. In vivo three-dimensional photoacoustic imaging of the renal vasculature in preclinical rodent models. Am J Physiol Renal Physiol. 2018;314(6):F1145-F53. [Crossref]  [PubMed] 
  119. Long DA, Norman JT, Fine LG. Restoring the renal microvasculature to treat chronic kidney disease. Nat Rev Nephrol. 2012;8(4):244-50. [Crossref]  [PubMed] 
  120. Maddox D. Deen WM, Brenner BM. Glomerular filtration. In: Windhager EE, ed. Handbook of Physiology Renal Physiology. Bethesda, MD: American Physiological Society; 1992. p.545-638.
  121. Homan KA, Kolesky DB, Skylar-Scott MA, Herrmann J, Obuobi H, Moisan A, et al. Bioprinting of 3D convoluted renal proximal tubules on perfusable chips. Sci Rep. 2016;6:34845. [Crossref]  [PubMed]  [PMC] 
  122. Mironov V, Boland T, Trusk T, Forgacs G, Markwald RR. Organ printing: computer-aided jet-based 3D tissue engineering. Trends Biotechnol. 2003;21(4):157-61. [Crossref]  [PubMed] 
  123. Mironov V, Kasyanov V, Drake C, Markwald RR. Organ printing: promises and challenges. Regen Med. 2008;3(1):93-103. [Crossref]  [PubMed] 
  124. Turunen S, Kaisto S, Skovorodkin I, Mironov V, Kalpio T, Vainio S, et al. 3D bioprinting of the kidney-hype or hope? AIMS Cell and Tissue Engineering. 2018;2(3):119-62. [Crossref] 
  125. King SM, Higgins JW, Nino CR, Smith TR, Paffenroth EH, Fairbairn CE, et al. 3D proximal tubule tissues recapitulate key aspects of renal physiology to enable nephrotoxicity testing. Front Physiol. 2017;8:123. [Crossref]  [PubMed]  [PMC] 
  126. Higgins JW, Chambon A, Bishard K, Hartung A, Arndt D, Brugnano J, et al. Bioprinted pluripotent stem cell-derived kidney organoids provide opportunities for high content screening. bioRxiv. 2018. [Crossref] 
  127. George SK, Abolbashari M, Kim TH, Zhang C, Allickson J, Jackson JD, et al. Effect of human amniotic fluid stem cells on kidney function in a model of chronic kidney disease. Tissue Eng Part A. 2019;25(21-22):1493-503. [Crossref]  [PubMed]  [PMC] 
  128. Bulanova EA, Koudan EV, Degosserie J, Heymans C, Pereira FD, Parfenov VA, et al. Bioprinting of a functional vascularized mouse thyroid gland construct. Biofabrication. 2017;9(3):034105. [Crossref]  [PubMed] 
  129. Molitch-Hou M. From 3D Printing Circuit Boards to Organs, Nano Dimension's CEO Discusses New Bioprinting Subsidiary 2017. Available from: [Link] 
  130. Beamish JA, Chen E, Putnam AJ. Engineered extracellular matrices with controlled mechanics modulate renal proximal tubular cell epithelialization. PLoS One. 2017;12(7):e0181085. [Crossref]  [PubMed]  [PMC] 
  131. Ozbolat IT, Hospodiuk M. Current advances and future perspectives in extrusion-based bioprinting. Biomaterials. 2016;76:321-43. [Crossref]  [PubMed] 
  132. Visconti RP, Kasyanov V, Gentile C, Zhang J, Markwald RR, Mironov V. Towards organ printing: engineering an intra-organ branched vascular tree. Expert Opin Biol Ther. 2010;10(3):409-20. [Crossref]  [PubMed]  [PMC] 
  133. Gentile C, Fleming PA, Mironov V, Argraves KM, Argraves WS, Drake CJ. VEGF-mediated fusion in the generation of uniluminal vascular spheroids. Dev Dyn. 2008;237(10):2918-25. [Crossref]  [PubMed]  [PMC] 
  134. Fleming PA, Argraves WS, Gentile C, Neagu A, Forgacs G, Drake CJ. Fusion of uniluminal vascular spheroids: a model for assembly of blood vessels. Dev Dyn. 2010;239(2):398-406. [Crossref]  [PubMed]  [PMC] 
  135. Nunes SS, Krishnan L, Gerard CS, Dale JR, Maddie MA, Benton RL, et al. Angiogenic potential of microvessel fragments is independent of the tissue of origin and can be influenced by the cellular composition of the implants. Microcirculation. 2010;17(7):557-67. [Crossref]  [PubMed]  [PMC] 
  136. 136.Laschke MW, Menger MD. Adipose tissue-derived microvascular fragments: natural vascularization units for regenerative medicine. Trends Biotechnol. 2015;33(8):442-8. [Crossref]  [PubMed] 
  137. Skardal A, Mack D, Kapetanovic E, Atala A, Jackson JD, Yoo J, et al. Bioprinted amniotic fluid-derived stem cells accelerate healing of large skin wounds. Stem Cells Transl Med. 2012;1(11):792-802. [Crossref]  [PubMed]  [PMC] 
  138. Cui X, Breitenkamp K, Finn MG, Lotz M, D'Lima DD. Direct human cartilage repair using three-dimensional bioprinting technology. Tissue Eng Part A. 2012;18(11-12):1304-12. [Crossref]  [PubMed]  [PMC] 
  139. Campbell PG, Weiss LE. Tissue engineering with the aid of inkjet printers. Expert Opin Biol Ther. 2007;7(8):1123-7. [Crossref]  [PubMed] 
  140. Tibbits S. 4D printing: multi-material shape change. Architectural Design. 2014;84(1):116-21. [Crossref] 
  141. Ge Q, Dunn CK, Qi HJ, Dunn ML. Active origami by 4D printing. Smart Materials and Structures. 2014;23(9):094007. [Crossref] 
  142. Pei E. 4D printing-revolution or fad? Assembly Automation. 2014;34(2):123-7. [Link] 
  143. Gao B, Yang Q, Zhao X, Jin G, Ma Y, Xu F. 4D bioprinting for biomedical applications. Trends Biotechnol. 2016;34(9):746-56. [Crossref]  [PubMed] 
  144. Morouço P, Gil JF. Four-dimensional bioprinting for regenerative medicine: mechanisms to induce shape variation and potential applications. EMJ Innovations. 2019;3(1):36-43. [Crossref] 
  145. Wang CJ, Hazlehurst KB. Orthopedic implant design and analysis: potential of 3D/4D bioprinting. In: Maniruzzaman M, ed. 3D and 4D Printing in Biomedical Applications: Process Engineering and Additive Manufacturing. Weinheim: John Wiley & Sons; 2019. p.423-42.
  146. Ong CS, Yesantharao P, Hibino N. 3D and 4D scaffold-free bioprinting. In: Maniruzzaman M, ed. 3D and 4D Printing in Biomedical Applications: Process Engineering and Additive Manufacturing. Weinheim: John Wiley & Sons; 2019. p.317-42. [Crossref]  [PubMed] 
  147. Liu J, Erol O, Pantula A, Liu W, Jiang Z, Kobayashi K, et al. Dual-gel 4D printing of bioinspired tubes. ACS Appl Mater Interfaces. 2019;11(8):8492-8. [Crossref]  [PubMed]  [PMC] 
  148. Miotto M, Gouveia RM, Ionescu AM, Figueiredo F, Hamley IW, Connon CJ. 4D Corneal Tissue Engineering: Achieving Time-Dependent Tissue Self-Curvature through Localized Control of Cell Actuators. Advanced Functional Materials. 2019:1807334. [Crossref] 
  149. Esmond RW, Phero GC. The additive manufacturing revolution and the corresponding legal landscape. Virtual and Physical Prototyping. 2015;10(1):9-12. [Crossref] 
  150. Aydın L, Küçük S, Kenar H. Doku ve organ biyo yazdırma amaçlı 3B biyo yazıcı tasarımı ve geliştirilmesi. Tıp Teknolojileri Ulusal Kongresi. 2015;1:153-7. [Link] 
  151. Bulus E, Sahin YM, Darici H, Sener LT. Investigation of the cellular behavior of polycaprolactone-hydroxyapatite tissue materials produced with bioprinter. International Journal of Scientific and Technological Research. 2019;5(1):148-61. [Link] 

.: Up To Date

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com